Back to Agenda
Session 3 Track 3:COVID-19 Experience from the Field – An HCP Panel
Session Chair(s)
Lori Mouser, PHARMD
Senior Director, Global Head of Oncology Scientific Engagement and Congresses, Daiichi Sankyo Inc., Switzerland
Paul Minne, PHARMD, RPH
Managing Director, Triple Helix Strategy, United States
This panel discussion will explore the impact of the COVID-19 pandemic on interactions with Health Care Providers (HCPs). A diverse group of HCPs will share their experiences of managing engagements with MSLs, attending virtual congresses, delivering care virtually and provide ideas on how these experiences may shape future approaches.
Learning Objective : At the conclusion of this session, participants should be able to:
- Discuss the primary challenges facing HCPs in conducting virtual engagements with MSLs
- List ways that virtual congress engagements have been successful for HCPs to access new data
- Identify future engagement strategies that meet HCP needs in the post COVID era
Speaker(s)
James S Pratty, MD
Assistant Clinical Professor, Psychiatry, University of California, Riverside, United States
Panelists
Melissa Mitchell, PHARMD
Senior Clinical Pharmacist – Special Projects, RUHS Medical Center, United States
Panelist
Joshua Sabari, MD
Attending Physician, Thoracic Medical Oncology, NYU Langone Health, Permutter Cancer Center, United States
Panelists
Have an account?